|
1. Available at:
http://www.cancer.org/docroot/PED/content/ped_7_1_What_You_Need_To_ Know_About_Skin_Cancer.asp.
Accessed April 29, 2008.
2. Hill L, Ferrini RL. Skin cancer prevention
and screening: summary of the American College
of Preventive Medicine’s practice policy
statements. CA Cancer J Clin. 1998
Jul-Aug;48(4):232-5.
3. Farage MA, Miller KW, Elsner P, Maibach
HI. Intrinsic and extrinsic factors in skin
ageing: a review. Int J Cosmet Sci. 2008
Apr;30(2):87-95.
4. Desai A, Krathen R, Orengo I, Medrano EE.
The age of skin cancers. Sci Aging Knowledge
Environ. 2006 May 24;2006(9):pe13.
5. Moriwaki S, Takahashi Y. Photoaging and
DNA repair. J Dermatol Sci. 2007 Oct 5 [Epub
ahead of print].
6. Hoey SE, Devereux CE, Murray L, et al.
Skin cancer trends in Northern Ireland and
consequences for provision of dermatology
services. Br J Dermatol. 2007 Jun;156(6):1301-7.
7. Available at:
http://www.skincancer.org/squamous/index.php. Accessed April 29, 2008.
8. Available at:
http://www.skincancer.org/melanoma/index.php.
Accessed April 29, 2008.
9. Grether-Beck S, Wlaschek M, Krutmann J,
Scharffetter-Kochanek K. Photodamage and
photoaging--prevention and treatment. J Dtsch
Dermatol Ges. 2005 Sep;3 Suppl 2:S19-25.
10. Available at:
http://www.ahrq.gov/clinic/3rduspstf/skcacoun/skcarr.htm.
Accessed April 29, 2008.
11. Available at:
http://www.umm.edu/skincancer/typesof.htm.Accessed
April 23, 2008.
12. Middelkamp-Hup MA, Pathak MA, Parrado C,
et al. Oral Polypodium leucotomos extract
decreases ultraviolet-induced damage of human
skin. J Am Acad Dermatol. 2004 Dec;51(6):910-8.
13. Philips N, Smith J, Keller T, Gonzalez S.
Predominant effects of Polypodium leucotomos on
membrane integrity, lipid peroxidation, and
expression of elastin and
matrixmetalloproteinase-1 in ultraviolet
radiation exposed fibroblasts, and
keratinocytes. J Dermatol Sci. 2003
Jun;32(1):1-9.
14. Jaczyk A, Garcia-Lopez MA,
Fernandez-Peñas P, et al. A Polypodium
leucotomos extract inhibits solar-simulated
radiation-induced TNF-alpha and iNOS expression,
transcriptional activation and apoptosis. Exp
Dermatol. 2007 Oct;16(10):823-9.
15. Alonso-Lebrero JL, Dominguez-Jimenez C,
Tejedor R, Brieva A, Pivel JP. Photoprotective
properties of a hydrophilic extract of the fern
Polypodium leucotomos on human skin cells. J
Photochem Photobiol B. 2003 Apr;70(1):31-7.
16. Shear NH. Fulfilling an unmet need in
psoriasis : do biologicals hold the key to
improved tolerability? Drug Saf.
2006;29(1):49-66.
17. Capella Perez MC, Castells RA.
Double-blind study using “anapsos” 120 mg. in
the treatment of psoriasis. Actas
Dermosifiliogr. 1981 Sep;72(9-10):487-94.
18. Del Pino GJ, De Sambricio GF, Colomo GC.
Comparative study between 120 mg. of anapsos and
a placebo in 37 psoriasis patients. Med Cutan
Ibero Lat Am. 1982;10:203-8.
19. Pineiro AB. 2 years personal experience
in anapsos treatment of psoriasis in various
clinical forms. Med Cutan Ibero Lat Am.
1983;11:65-72.
20. Gonzalez S, Pathak MA. Inhibition of
ultraviolet-induced formation of reactive oxygen
species, lipid peroxidation, erythema and skin
photosensitization by polypodium leucotomos.
Photodermatol Photoimmunol Photomed. 1996
Apr;12(2):45-56.
21. Gonzalez S, Pathak MA, Cuevas J,
Villarrubia VG, Fitzpatrick TB. Topical or oral
administration with an extract of Polypodium
leucotomos prevents acute sunburn and psoralen-induced
phototoxic reactions as well as depletion of
Langerhans cells in human skin. Photodermatol
Photoimmunol Photomed. 1997 Feb;13(1-2):50-60.
22. Middelkamp-Hup MA, Pathak MA, Parrado C,
et al. Orally administered Polypodium leucotomos
extract decreases psoralen-UVA-induced
phototoxicity, pigmentation, and damage of human
skin. J Am Acad Dermatol. 2004 Jan;50(1):41-9.
23. Caccialanza M, Percivalle S, Piccinno R,
Brambilla R. Photoprotective activity of oral
polypodium leucotomos extract in 25 patients
with idiopathic photodermatoses. Photodermatol
Photoimmunol Photomed. 2007 Feb;23(1):46-7.
24. Gonzalez S, Alonso-Lebrero JL, Del RR,
Jaen P. Polypodium leucotomos extract: a
nutraceutical with photoprotective properties.
Drugs Today (Barc). 2007 Jul;43(7):475-85.
25. Gomes AJ, Lunardi CN, Gonzalez S, Tedesco
AC. The antioxidant action of Polypodium
leucotomos extract and kojic acid: reactions
with reactive oxygen species. Braz J Med Biol
Res. 2001 Nov;34(11):1487-94.
26. Emanuel P, Scheinfeld N. A review of DNA
repair and possible DNA-repair adjuvants and
selected natural anti-oxidants. Dermatol Online
J. 2007;13(3):10.
27. Capote R, Alonso-Lebrero JL, Garcia F, et
al. Polypodium leucotomos extract inhibits
trans-urocanic acid photoisomerization and
photodecomposition. J Photochem Photobiol B.
2006 Mar 1;82(3):173-9.
28. Erb P, Ji J, Kump E, Mielgo A, Wernli M.
Apoptosis and pathogenesis of melanoma and
nonmelanoma skin cancer. Adv Exp Med Biol.
2008;624:283-95.
29. Available at:
http://www.medicinenet.com/skin_cancer/article.htm.
Accessed April 23, 2008.
30. Talalay P, Fahey JW, Healy ZR, et al.
Sulforaphane mobilizes cellular defenses that
protect skin against damage by UV radiation.
Proc Natl Acad Sci USA. 2007 Oct
30;104(44):17500-5.
31. Cooper SJ, Bowden GT. Ultraviolet B
regulation of transcription factor families:
roles of nuclear factor-kappa B (NF-kappaB) and
activator protein-1 (AP-1) in UVB-induced skin
carcinogenesis. Curr Cancer Drug Targets. 2007
Jun;7(4):325-34.
32. Montaner B, O’Donovan P, Reelfs O, et al.
Reactive oxygen-mediated damage to a human DNA
replication and repair protein. EMBO Rep. 2007
Nov;8(11):1074-9.
33. Schwarz T. Mechanisms of UV-induced
immunosuppression. Keio J Med. 2005
Dec;54(4):165-71.
34. Runger TM. How different wavelengths of
the ultraviolet spectrum contribute to skin
carcinogenesis: the role of cellular damage
responses. J Invest Dermatol. 2007
Sep;127(9):2103-5.
35. Svobodova A, Zdarilova A, Walterova D,
Vostalova J. Flavonolignans from Silybum
marianum moderate UVA-induced oxidative damage
to HaCaT keratinocytes. J Dermatol Sci. 2007
Dec;48(3):213-24.
36. Rogers GS, Gilchrest BA. The senile
epidermis: environmental influences on skin
ageing and cutaneous carcinogenesis. Br J
Dermatol. 1990 Apr;122 Suppl 35:55-60.
37. Takashima A. UVB-dependent modulation of
epidermal cytokine network: roles in UVB-induced
depletion of Langerhans cells and dendritic
epidermal T cells. J Dermatol. 1995
Nov;22(11):876-87.
38. Yaar M, Gilchrest BA. Photoageing:
mechanism, prevention and therapy. Br J Dermatol.
2007 Nov;157(5):874-87.
39. Lubeck RP, Berneburg M, Trelles M. et al.
How best to halt and/or revert UV-induced skin
ageing: strategies, facts and fiction. Exp
Dermatol. 2008 Mar;17(3):228-40.
40. Available at:
http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijge/vol4n2/melanoma.xml.
Accessed April 29, 2008.
41. Available at:
http://www.skincarephysicians.com/skincancernet/four_types.html.
Accessed April 29, 2008.
42. Available at:
http://www.cancer.gov/cancertopics/pdq/treatment/intraocularmelanoma/Patient.
Accessed April 29, 2008.
43. Available at:
http://www.skincancer.org/melanoma/melanoma_3.html.
Accessed April 29, 2008.
44. Available at:
http://www.emedicine.com/plastic/topic376.htm.
Accessed April 29, 2008.
45. Anon. Screening for cancer: colon, lung
and skin cancers. Harv Mens Health Watch. 2005
Oct;10(3):1-5.
|